Assuming announce is required, the following results were found.

  • Breaking: U.S. FDA to Announce Sept. 9 PMTA Deadline

    While not yet official, the deadline for submitting premarket tobacco product authorizations (PMTA) to the U.S. Food and Drug Administration (FDA) is one step closer to being delayed from May 12, 2020 to Sept. 9, 2020 due to the Covid-19 pandemic....

    https://www.mschristian.org/index.php/articles/2-uncategorised/10486-breaking-u-s-fda-to-announce-sept-9-pmta-deadline
  • Breaking: U.S. FDA to Announce Sept. 9 PMTA Deadline

    While not yet official, the deadline for submitting premarket tobacco product authorizations (PMTA) to the U.S. Food and Drug Administration (FDA) is one step closer to being delayed from May 12, 2020 to Sept. 9, 2020 due to the Covid-19 pandemic....

    https://www.mschristian.org/index.php/component/easyblog/breaking-u-s-fda-to-announce-sept-9-pmta-deadline?Itemid=341
  • NARCRMS ENROLLMENT MILESTONE: 700 MULTIPLE SCLEROSIS PARTICIPANTS ENROLLED

    (CMSC) (Hackensack, NJ, March 2020) — The North American Registry for Care and Research in MS (NARCRMS) is pleased to announce enrollment of its 700th patient on Wednesday, February 26, 2020. NARCRMS anticipates enrolling up to 1,250 patients across 30...

    https://www.mschristian.org/index.php/component/easyblog/narcrms-enrollment-milestone-700-multiple-sclerosis-participants-enrolled?Itemid=341
  • Maria T. Schultheis Joins Office of Research & Innovation Leadership Team - DrexelNow - Drexel Now

    Saunders, PhD: To support the growth of the University’s research, scholarly and creative activities, I am pleased to announce the appointment of Maria T. Schultheis, PhD, as the Vice Provost of Research. Schultheis, a clinical neuropsychologist, is...

    https://www.mschristian.org/index.php/component/easyblog/maria-t-schultheis-joins-office-of-research-innovation-leadership-team-drexelnow-drexel-now?Itemid=341
  • NIH To Stop Trial On Controversial Anti-Malarial Drug; Scientists Excited About Osteoperosis Medication - Kaiser Health News

    and biological tests, according to Politico. (Budryk, 6/18) Earlier this week, researchers in the United Kingdom announced preliminary results from a clinical trial that showed a low-cost steroid called dexamethasone appeared to lower the risk of death...

    https://www.mschristian.org/index.php/articles/2-uncategorised/10888-nih-to-stop-trial-on-controversial-anti-malarial-drug-scientists-excited-about-osteoperosis-medication-kaiser-health-news
  • Vapor companies complain about S. Korea government’s anti-vaping stance

    Ministry of Food and Drug Safety is conducting an e-cigarette risk investigation. Minister Lee Eui-kyung was supposed to announce the results of the probe in November, but no announcement has been made so far according to a story at businesskorea.co.kr....

    https://www.mschristian.org/index.php/articles/2-uncategorised/9580-vapor-companies-complain-about-s-korea-government-s-anti-vaping-stance
  • Maria T. Schultheis Joins Office of Research & Innovation Leadership Team - DrexelNow - Drexel Now

    Saunders, PhD: To support the growth of the University’s research, scholarly and creative activities, I am pleased to announce the appointment of Maria T. Schultheis, PhD, as the Vice Provost of Research. Schultheis, a clinical neuropsychologist, is...

    https://www.mschristian.org/index.php/articles/2-uncategorised/9550-maria-t-schultheis-joins-office-of-research-innovation-leadership-team-drexelnow-drexel-now
  • New treatment shows promise to reverse celiac disease

    and Drug Administration, and brought the therapy to patients in collaboration with Takeda Pharmaceuticals. Takeda will announce Tuesday they have acquired an exclusive global license to develop and commercialize this investigational medicine for celiac...

    https://www.mschristian.org/index.php/articles/2-uncategorised/8995-new-treatment-shows-promise-to-reverse-celiac-disease
  • NARCRMS ENROLLMENT MILESTONE: 700 MULTIPLE SCLEROSIS PARTICIPANTS ENROLLED

    (CMSC) (Hackensack, NJ, March 2020) — The North American Registry for Care and Research in MS (NARCRMS) is pleased to announce enrollment of its 700th patient on Wednesday, February 26, 2020. NARCRMS anticipates enrolling up to 1,250 patients across 30...

    https://www.mschristian.org/index.php/articles/2-uncategorised/10597-narcrms-enrollment-milestone-700-multiple-sclerosis-participants-enrolled
  • New treatment shows promise to reverse celiac disease

    and Drug Administration, and brought the therapy to patients in collaboration with Takeda Pharmaceuticals. Takeda will announce Tuesday they have acquired an exclusive global license to develop and commercialize this investigational medicine for celiac...

    https://www.mschristian.org/index.php/component/easyblog/new-treatment-shows-promise-to-reverse-celiac-disease?Itemid=341

Results 1 - 10 of 10